Within this context, Yang et al. (2017) investigated a series of pyridoxine–resveratrol hybrid molecules, emphasizing their dual inhibitory activity against AChE and MAO-B, two key enzymes involved in the progression of AD [208]. Here, ACHE is linked to Alzheimer disease.